Valeant Still Holding Off On DTC Ads For Controversial Female Sex Pill
This article was originally published in The Pink Sheet Daily
Executive Summary
The female libido enhancing drug Addyi (flibanserin) has drawn a lot of attention, but the sponsor is making less of a splash with the launch.